Rare diseases
Investigational molecules
Locations
Back to Germany29 clinical trials in Bad Berka, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Effects of MBS2320 for Patients with Idiopathic Pulmonary Fibrosis (IPF)
GermanyStudy of Pembrolizumab with Chemotherapy for Patients with Resectable Stage II, IIIA, and IIIB Non-Small Cell Lung Cancer
GermanyStudy of Pembrolizumab and Olaparib with Chemoradiation for Patients with Stage III Non-Small Cell Lung Cancer
GermanyStudy on the Effectiveness and Safety of MK-0616 for Adults with High Cholesterol
GermanyStudy of Ramucirumab and Dacarbazine for Patients with Progressive Metastatic Pancreatic Neuroendocrine Tumors
GermanyThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies focusing on various types of non-small cell lung cancer and small cell lung cancer, evaluating novel therapeutic approaches and combination treatments.
Multiple trials exploring immunotherapy combinations and targeted therapies for different lung cancer subtypes.
Innovative research examining treatments for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis, with a focus on improving lung function and quality of life.
Studies evaluating both established and experimental treatments for fibrotic lung conditions.
Clinical investigations into neuroendocrine tumors, particularly focusing on gastroenteric and pancreatic origins, testing innovative therapeutic approaches.
Trials examining novel treatment combinations and targeted therapies for neuroendocrine neoplasms.
Research focusing on managing hypercholesterolemia through innovative therapeutic approaches and long-term treatment strategies.
Studies evaluating new medications and their impact on cholesterol levels and cardiovascular health.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
